Literature DB >> 10825057

Influenza B virus encephalitis.

J A McCullers1, S Facchini, P J Chesney, R G Webster.   

Abstract

Acute encephalitis and postinfectious encephalopathy have been reported infrequently in association with influenza A and B virus infections. We report herein a case of a 6-year-old girl with acute influenza B virus encephalitis resulting in neurological sequelae. The diagnosis was made by isolation of influenza B virus from the nasopharynx, seroconversion to influenza B, and reverse transcription polymerase chain reaction (RT-PCR) identification of the virus from the patient's cerebrospinal fluid. Direct sequencing of viral RNA from the patient's nasopharynx and cerebrospinal fluid revealed identical nucleotide sequences in the HA1 region of the hemagglutinin gene. This is the first report of influenza B virus encephalitis diagnosed by use of RT-PCR and illustrates the need for increased awareness of influenza virus as a cause of acute encephalitis. PCR may be a useful tool for diagnosing future cases.

Entities:  

Mesh:

Year:  1999        PMID: 10825057     DOI: 10.1086/515214

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  21 in total

1.  Lack of detection of influenza genes in archived formalin-fixed, paraffin wax-embedded brain samples of encephalitis lethargica patients from 1916 to 1920.

Authors:  K C Lo; J F Geddes; R S Daniels; J S Oxford
Journal:  Virchows Arch       Date:  2003-04-15       Impact factor: 4.064

Review 2.  The ecology of emerging neurotropic viruses.

Authors:  Kevin J Olival; Peter Daszak
Journal:  J Neurovirol       Date:  2005-10       Impact factor: 2.643

Review 3.  The burden of influenza B: a structured literature review.

Authors:  W Paul Glezen; Jordana K Schmier; Carrie M Kuehn; Kellie J Ryan; John Oxford
Journal:  Am J Public Health       Date:  2013-01-17       Impact factor: 9.308

4.  Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial.

Authors:  Pedro A Piedra; Manjusha J Gaglani; Mark Riggs; Gayla Herschler; Charles Fewlass; Matt Watts; Claudia Kozinetz; Colin Hessel; W Paul Glezen
Journal:  Pediatrics       Date:  2005-09       Impact factor: 7.124

5.  Efficacy of zanamivir against avian influenza A viruses that possess genes encoding H5N1 internal proteins and are pathogenic in mammals.

Authors:  I A Leneva; O Goloubeva; R J Fenton; M Tisdale; R G Webster
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

6.  Wild-type and attenuated influenza virus infection of the neonatal rat brain.

Authors:  Steven Rubin; Dong Liu; Mikhail Pletnikov; Jonathan McCullers; Zhiping Ye; Roland Levandowski; Jan Johannessen; Kathryn Carbone
Journal:  J Neurovirol       Date:  2004-10       Impact factor: 2.643

7.  Genetic contributions to influenza virus attenuation in the rat brain.

Authors:  Li Qi; Kathryn M Carbone; Zhiping Ye; Teresa Liu; Mikhail Ovanesov; Mikhail Pletnikov; Christian Sauder; Steven A Rubin
Journal:  J Neurovirol       Date:  2008-04       Impact factor: 2.643

8.  Influenza and respiratory syncytial virus in infants and children: relationship with attendance at a paediatric emergency unit and characteristics of the circulating strains.

Authors:  R Gasparini; P Durando; F Ansaldi; L Sticchi; F Banfi; D Amicizia; D Panatto; S Esposito; N Principi; G Icardi; P Crovari
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-09       Impact factor: 3.267

9.  Identification and characterization of viral defective RNA genomes in influenza B virus.

Authors:  Zizhang Sheng; Runxia Liu; Jieshi Yu; Zhiguang Ran; Simon J Newkirk; Wenfeng An; Feng Li; Dan Wang
Journal:  J Gen Virol       Date:  2018-02-12       Impact factor: 3.891

Review 10.  Infectious diseases and vaccine sciences: strategic directions.

Authors:  Stephen P Luby; W Abdullah Brooks; K Zaman; Shahed Hossain; Tahmeed Ahmed
Journal:  J Health Popul Nutr       Date:  2008-09       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.